For health services and systems
Two patients with the same molecular profile should receive the same quality of analysis, whichever centre they attend. Today that equality depends on each hospital's resources. Sphera is designed to narrow that gap from the level of system management, not only from the individual clinic.
When every tumor board in the network works from the same knowledge base and the same interpretation rules, the quality of molecular analysis stops depending on where the diagnosis is made. Criteria become consistent without standardising the decision, which remains clinical and belongs to each team.
Not every hospital has molecular biology specialists available to interpret each NGS panel. OncoCore gives those centres a first level of structured, referenced analysis that organises the case before it is referred or discussed at a board.
With every statement linked to its source, decisions can be reviewed, processes audited and external assessments answered with documented evidence. For a health service, that traceability is a governance instrument, not only a clinical safeguard.
The modular architecture allows the platform to be rolled out in stages across a network of centres, with options ranging from centralised hosting to installation on each hospital's own infrastructure, according to the health service's policies.
OncoCore is in a development and clinical evaluation phase, with its knowledge base consolidated for non-small cell lung cancer (NSCLC). For a health service, this moment is an opportunity: taking part in the evaluation means influencing design criteria — formats, integration, deployment models — before any decision on implementation at scale.
We work under formal agreements aligned with each institution's requirements, and process data in accordance with the GDPR and each centre's procedures.
If you manage a health service or a hospital network and want to explore how precision oncology can be made consistent across your centres, write to us.
